Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ZLAB | CLUSTER | bearish | 7/10 | Zai Lab's CEO Du Ying exercised and sold shares across multiple transactions, generating $1.92M from open-market sales. | Mar 10, 2026 |
| TWST | CLUSTER | bearish | 5/10 | Three insiders at Twist Bioscience sold shares in a coordinated 7-day window, including CEO Emily Leproust, who sold $11 | Mar 10, 2026 |
| ANIP | CLUSTER | neutral | 3/10 | ANI Pharmaceuticals CFO Stephen P. Carey surrendered 5,150 shares to cover tax obligations in connection with a vesting | Mar 10, 2026 |
| QURE | CLUSTER | neutral | 2/10 | Multiple C-suite executives at uniQure N.V. received non-cash stock awards totaling 0 shares at $0 value on 2026-03-04. | Mar 9, 2026 |
| ADPT | CLUSTER | neutral | 3/10 | Adaptive Biotechnologies insiders saw a cluster of share award grants across executives and directors, with one open-mar | Mar 9, 2026 |
| TECX | CLUSTER | neutral | 4/10 | Tectonic Therapeutic insiders executed a mix of open-market sales and non-cash derivative/award transactions over the pa | Mar 9, 2026 |
| JAZZ | CLUSTER | neutral | 3/10 | A cluster of insider transactions at Jazz Pharmaceuticals over the past week includes one open-market sale by an SVP and | Mar 9, 2026 |
| JAZZ | CLUSTER | neutral | 3/10 | A cluster of insider transactions at Jazz Pharmaceuticals over the past week includes one open-market sale by the Chief | Mar 9, 2026 |
| PTCT | CLUSTER | bearish | 6/10 | Three corporate insiders at PTC Therapeutics sold shares in a coordinated 7-day window, including the Chief Medical Offi | Mar 9, 2026 |
| MGX | CLUSTER | neutral | 2/10 | Two insiders at Metagenomi Therapeutics sold shares in a recent 7-day window, including CEO Irish Jian who sold 1,607 sh | Mar 9, 2026 |
| JAZZ | CLUSTER | neutral | 4/10 | A cluster of insider transactions at Jazz Pharmaceuticals over the past week includes one open-market sale by the Chief | Mar 9, 2026 |
| JAZZ | CLUSTER | neutral | 4/10 | A recent insider trading cluster at Jazz Pharmaceuticals includes a significant open-market sale by director Bruce Cozad | Mar 9, 2026 |
| LYEL | CLUSTER | bullish | 8/10 | Two funds affiliated with ARCH Venture Partners collectively purchased nearly $25 million worth of Lyell Immunopharma sh | Mar 9, 2026 |
| UTHR | CLUSTER | neutral | 5/10 | United Therapeutics CEO Martine Rothblatt and several insiders engaged in a series of derivative exercises and open-mark | Mar 9, 2026 |
| TKNO | CLUSTER | bullish | 6/10 | Alpha Teknova's CFO and CEO made open-market purchases totaling $143,417 in the past week, with the CFO buying 40,000 sh | Mar 9, 2026 |
| TEVA | CLUSTER | bearish | 6/10 | Seven executives at Teva Pharmaceutical exercised stock derivatives and several conducted open-market sales totaling app | Mar 9, 2026 |
| TEVA | CLUSTER | neutral | 4/10 | Seven executives at Teva Pharmaceutical exercised stock options and sold shares in the open market on March 5, 2026, gen | Mar 9, 2026 |
| CSTL | CLUSTER | neutral | 3/10 | Castle Biosciences insiders executed a cluster of transactions over the past week, primarily involving derivative exerci | Mar 9, 2026 |
| AGIO | CLUSTER | neutral | 3/10 | Two insiders at Agios Pharmaceuticals sold shares in the past week, including the Chief Corporate Development & Strategy | Mar 9, 2026 |
| TEVA | CLUSTER | neutral | 3/10 | Teva executives executed derivative exercises and received share grants totaling $0 in cash value, with only two open-ma | Mar 9, 2026 |
| XNCR | CLUSTER | neutral | 3/10 | Five open-market share sales by three Xencor executives, CEO, CFO, and General Counsel, over two days, totaling $324,274 | Mar 9, 2026 |
| TEVA | CLUSTER | neutral | 4/10 | Multiple Teva executives, including the CEO, CFO, and other C-suite officers, exercised stock options and received share | Mar 9, 2026 |
| ARVN | CLUSTER | neutral | 3/10 | A director at Arvinas, Inc. purchased $268,070 worth of shares in an open-market transaction, marking the only insider a | Mar 9, 2026 |
| AMLX | CLUSTER | neutral | 3/10 | Seven executives at Amylyx Pharmaceuticals, including both Co-CEOs, the CFO, CMO, and Chief Legal Officer, were awarded | Mar 9, 2026 |
| ALT | CLUSTER | neutral | 4/10 | Altimmune's CEO and CFO collectively purchased $88,490 worth of shares in open-market transactions on March 6, 2026, sig | Mar 9, 2026 |
| MDGL | CLUSTER | neutral | 4/10 | Seven insiders at Madrigal Pharmaceuticals, including the CEO, CFO, and other C-suite executives, conducted open-market | Mar 6, 2026 |
| KRYS | CLUSTER | neutral | 3/10 | Krystal Biotech CEO Krishnan Krish and Chief Accounting Officer Kathryn Romano sold shares in the open market, totaling | Mar 6, 2026 |
| MDGL | CLUSTER | neutral | 3/10 | Two Madrigal Pharmaceuticals insiders conducted open-market sales totaling $717K in the past week, including CFO Mardi D | Mar 6, 2026 |
| SDGR | CLUSTER | neutral | 3/10 | Multiple Schrodinger executives, including the CEO and CFO, received stock awards as part of what appears to be a routin | Mar 6, 2026 |
| QURE | CLUSTER | neutral | 4/10 | uniQure's top executives, including the CEO, CFO, CMO, and Chief Legal Officer, were granted stock awards totaling over | Mar 6, 2026 |